Synthesis, cytotoxic and urease inhibitory activities of some novel isatin-derived bis-Schiff bases and their copper(ii) complexes12. Issue 5 (7th March 2016)

• Record Type: Journal Article
• Authors: Pervez, Humayun; Ahmad, Maqbool; Zaib, Sumera; Yaqub, Muhammad; Naseer, Muhammad Moazzam; Iqbal, Jamshed
• Is Part Of: MedChemComm. Volume 7:Issue 5(2016:May)
• Page Start: 914
• Page End: 923
• Publication Date: 2016-03-07
• Subjects: Pharmaceutical chemistry -- Periodicals; 615.19
• DOI: 10.1039/c5md00529a
• Languages: English
• ISSNs: 2040-2503

Abstract

Abstract : The putative binding mode of the most active compound3b in the active site of Jack bean urease. Abstract : Several isatin-3-thiosemicarbazones (a class of Schiff bases) from our earlier studies have been validated as promising cytotoxic agents and urease inhibitors. Also, a number of isatin-derived imines (Schiff bases) and their Cu(ii ) complexes have been reported in the literature to exhibit potential cytotoxic activity towards different cells. In view of this, a series of seven new 5-(un)-substituted isatin-derived bis-Schiff bases/ligands3a–g and their Cu(ii ) complexes5a–g were synthesized and evaluated for their cytotoxic and urease inhibitory activities. All the Schiff base ligands3a–g proved to be active in sulforhodamine B (SRB) bioassay, displaying promising cytotoxic activity against lung carcinoma (H157) cells. Compound3b was found to be the most potent inhibitor of H157 cells, exhibiting an IC50 value of 2.32 ± 0.11 μM. Similarly, all the metal complexes5a–g proved to be active in this assay, demonstrating enhanced cytotoxic activity in each case, occurring as a result of coordination of the Schiff base ligands to the metal ion. Compound5d proved to be the most potent inhibitor of H157 cells, showing cytotoxic activity comparable to that of the standard drug, vincristine (VCN) (IC50 = 1.29 ± 0.06 vs. 1.03 ± 0.04 μM). In the urease inhibition assay, all the synthesized Schiff base ligands except3f proved to be highly potent enzyme inhibitors, displaying inhibitory activity even better than that of the reference inhibitor, thiourea (IC50 = 0.04 ± 0.004–5.86 ± 0.09 vs. 22.3 ± 1.12 μM), and thus may act as promising lead molecules for further studies. Molecular docking studies were also carried out for bis-Schiff bases3a–g to elucidate their relationship with the binding pockets of the enzyme.